Lv1
34 积分 2025-10-11 加入
PCSK9 inhibitor added to high-intensity statin therapy to prevent cardiovascular events in patients with acute coronary syndrome after percutaneous coronary intervention: a randomized, double- blind, placebo-controlled, multicenter SHAWN study
1个月前
已完结
Lenacapavir: A novel injectable HIV-1 capsid inhibitor
1个月前
已完结
Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women
1个月前
已完结
Serum alkaline phosphatase isoenzymes as markers of liver disease
2个月前
已关闭
Alkaline Phosphatases: Biochemistry, Functions, and Measurement
2个月前
已完结
Kidney Alkaline Phosphatase in Mercuric Chloride Injected Chicks Resistant and Susceptible to Leukosis ,
2个月前
已完结
“症状-药物教学法”在传出神经系统药理总论教学中的应用
3个月前
已完结
Efficacy and safety of alirocumab among individuals with diabetes mellitus and atherosclerotic cardiovascular disease in the ODYSSEY phase 3 trials
4个月前
已完结
Effect of PCSK9 inhibitor usage on coronary endothelial dysfunction in patients with hypercholesterolemia after coronary stenting: the CuVIC-2 trial
4个月前
已关闭
Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction
4个月前
已完结
皖公网安备34019202002308
